Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanlong Ma

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Prostate|January 10, 2018
Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancerMaher Albitar, Wanlong Ma, Lars Lund, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Leukemia Research|September 23, 2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)Ellin Berman, Suresh Jhanwar, Cyrus Hedvat, et al.
Cancer|January 29, 2008
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemiaWanlong Ma, Hagop Kantarjian, Susan O'Brien, et al.
Haematologica|February 14, 2007
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemiaWanlong Ma, Richard Tseng, Mercedes Gorre, et al.
Frontiers in Neurology|November 7, 2022
The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolutionXuhong Yang, Pei Dang, Wenxiao Liu, et al.
Leukemia Research|April 6, 2010
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemiaJean-Marie Bruey, Hagop Kantarjian, Wanlong Ma, et al.
Journal of Gastroenterology and Hepatology|March 23, 2011
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver diseaseKevin Z Qu, Ke Zhang, Wanlong Ma, et al.
Plos One|August 24, 2010
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasmsWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Leukemia Research|August 15, 2009
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemiaJean-Marie Bruey, Hagop Kantarjian, Zeev Estrov, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Prostate|January 10, 2018
Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancerMaher Albitar, Wanlong Ma, Lars Lund, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Leukemia Research|September 23, 2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)Ellin Berman, Suresh Jhanwar, Cyrus Hedvat, et al.
Cancer|January 29, 2008
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemiaWanlong Ma, Hagop Kantarjian, Susan O'Brien, et al.
Haematologica|February 14, 2007
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemiaWanlong Ma, Richard Tseng, Mercedes Gorre, et al.
Frontiers in Neurology|November 7, 2022
The role of butyrylcholinesterase in the regulation of cognitive dysfunction in minimal hepatic encephalopathy: A potential blood marker of disease evolutionXuhong Yang, Pei Dang, Wenxiao Liu, et al.
Leukemia Research|April 6, 2010
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemiaJean-Marie Bruey, Hagop Kantarjian, Wanlong Ma, et al.
Journal of Gastroenterology and Hepatology|March 23, 2011
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver diseaseKevin Z Qu, Ke Zhang, Wanlong Ma, et al.
Plos One|August 24, 2010
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasmsWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Leukemia Research|August 15, 2009
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemiaJean-Marie Bruey, Hagop Kantarjian, Zeev Estrov, et al.
Pageof 4